Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-14 · accession 0002044279-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | 2025-12-14 | EBS | Lowry Simon C | SVP, CMO, R, D | F - Tax | $11.41 | -3,543 | 88.4K | -4% | -$40.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-14 | F | D | 3,543 | $11.41 | 88,439 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |